The Australian share market certainly is not short of blue chips. But which ones should you buy over others?
To help narrow things down, listed below are two top blue chip ASX 200 shares that are rated as buys by experts. They are as follows:
CSL Limited (ASX: CSL)
The first blue chip ASX 200 share to consider is CSL. It is one of the worldâs leading biotechnology companies and the name behind the CSL Behring and Seqirus businesses. CSL Behring is the global leader in a plasma therapies industry, whereas Seqirus is the number two player in the global influenza vaccines industry.
CSL has also just completed the acquisition of Vifor Pharma. This business, now known as CSL Vifor, is the global specialty pharmaceutical leader in iron deficiency, nephrology (kidney care), and cardio-renal therapies.
All three businesses appear well-placed for growth over the long term thanks to their high quality products and lucrative research and development pipelines. In addition, improving plasma collection conditions should be a boost to the company’s margins in the near term.
Citi is positive on CSL and currently has a buy rating and $340.00 price target on its shares.
Goodman Group (ASX: GMG)
Another blue chip ASX 200 share that has been tipped as a buy is Goodman Group.
It is a leading integrated commercial and industrial property company with a portfolio of high quality properties. Many of these properties have exposure to key growth markets such as ecommerce and logistics where demand is particularly strong. This has underpinned stellar earnings growth in recent years.
The team at Goldman Sachs believes that this strong form can continue thanks to “a number of favourable fundamentals underpinning future long-term demand for industrial space.” For example, it expects this to lead to operating earnings per share growth of ~17% in FY 2023.
Goldman has a buy rating and $25.40 price target on its shares.
The post 2 blue chip ASX 200 shares to boost your portfolio: experts appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of September 1 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- The CSL share price has gone backwards in 2022. Could a turnaround be ‘just starting to happen’?
- ASX 200 better buy: Cochlear or CSL shares?
- Goodman share price crumbles 5% amid Wall St woes
- The CSL share price dips as the ASX 200 dives on Wednesday
- Why I’m seriously considering buying these ASX shares following today’s market crash
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/TZDrOg7
Stock Pick 